» Articles » PMID: 19003333

Influence of Osmolarity and PH Increase to Achieve a Reduction of Monoclonal Antibodies Aggregates in a Production Process

Overview
Journal Cytotechnology
Specialties Biotechnology
Genetics
Date 2008 Nov 13
PMID 19003333
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Anti PSA monoclonal antibodies for diagnostic use were produced in an in vitro system. After purification using Protein G affinity chromatography a percentage of about 10% of antibody aggregates remained. The use of monoclonal antibodies containing aggregates as a capture antibody in a diagnostic kit reduces the performance of the test making it often unacceptable. The aggregates could be eliminated using gel filtration chromatography but, in that way, the final recovery of the whole production process was only about 50%. Aggregation is favoured when the working pH is near to the isoelectric point of the antibody. We varied the culture medium composition, modifying pH and osmolarity. We tested different values of pH and osmolarity: 7.1, 7.5, 8.0, 8.5 for pH, and 300, 340, 367, 395 mOsm/kg H2O for osmolarity. By modification of the cell culture medium we obtained a significant decrease of monoclonal antibody aggregates in the production cycle. In this way we achieved higher recovery rate and could avoid gel filtration polishing step. The experiments were performed in two stages: first in culture flasks changing one parameter in each experiment, and then in spinner bottle using the best conditions obtained in the first stage. During scale up we used the modifications achieved from the experiment showed in this paper in our production by hollow fibre bioreactor with positive results.

Citing Articles

Process- and Product-Related Foulants in Virus Filtration.

Isu S, Qian X, Zydney A, Wickramasinghe S Bioengineering (Basel). 2022; 9(4).

PMID: 35447715 PMC: 9030149. DOI: 10.3390/bioengineering9040155.


Main Quality Attributes of Monoclonal Antibodies and Effect of Cell Culture Components.

Torkashvand F, Vaziri B Iran Biomed J. 2017; 21(3):131-41.

PMID: 28176518 PMC: 5392216. DOI: 10.18869/acadpub.ibj.21.3.131.


Investigation of the interactions of critical scale-up parameters (pH, pO and pCO) on CHO batch performance and critical quality attributes.

Brunner M, Fricke J, Kroll P, Herwig C Bioprocess Biosyst Eng. 2016; 40(2):251-263.

PMID: 27752770 PMC: 5274649. DOI: 10.1007/s00449-016-1693-7.


Characterization of Aggregation Propensity of a Human Fc-Fusion Protein Therapeutic by Hydrogen/Deuterium Exchange Mass Spectrometry.

Huang R, Iacob R, Krystek S, Jin M, Wei H, Tao L J Am Soc Mass Spectrom. 2016; 28(5):795-802.

PMID: 27527097 DOI: 10.1007/s13361-016-1452-7.


Functionalized micro-capillary film for the rapid at-line analysis of IgG aggregates in a cell culture bioreactor.

Townsend M, Gruber D, Kuiper M, Lazar R, Field R, Turner R MAbs. 2015; 7(5):812-9.

PMID: 26176737 PMC: 4623336. DOI: 10.1080/19420862.2015.1065365.


References
1.
Guse A, Milton A, Schulze-Koops H, Muller B, Roth E, Simmer B . Purification and analytical characterization of an anti-CD4 monoclonal antibody for human therapy. J Chromatogr A. 1994; 661(1-2):13-23. DOI: 10.1016/0021-9673(94)85173-5. View

2.
Bibila T, Ranucci C, Glazomitsky K, Buckland B, Aunins J . Monoclonal antibody process development using medium concentrates. Biotechnol Prog. 1994; 10(1):87-96. DOI: 10.1021/bp00025a011. View

3.
Akerstrom B, Brodin T, Reis K, Bjorck L . Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies. J Immunol. 1985; 135(4):2589-92. View

4.
Reddy S, Bauer K, Miller W . Determination of antibody content in live versus dead hybridoma cells: analysis of antibody production in osmotically stressed cultures. Biotechnol Bioeng. 1992; 40(8):947-64. DOI: 10.1002/bit.260400811. View

5.
Ozturk S, Palsson B . Effect of medium osmolarity on hybridoma growth, metabolism, and antibody production. Biotechnol Bioeng. 1991; 37(10):989-93. DOI: 10.1002/bit.260371015. View